Unity Biotechnology (NASDAQ:UBX) Price Target Cut to $5.00 :

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price reduced by Wedbush from $35.00 to $5.00 in a report issued on Tuesday, The Fly reports. They currently have an outperform rating on the stock. Wedbush also issued estimates for Unity Biotechnology’s FY2026 earnings at ($12.94) EPS and FY2027 earnings at ($15.07) EPS. Several other […]

Related Keywords

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Renaissance Technologies , Virtu Financial , Unity Biotechnology Inc , Acadian Asset Management , Citigroup , Unity Biotechnology , Get Rating , Asset Management , Street Corp , Exoduspoint Capital Management , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Subx , Medical , Lower Price Target , Wedbush ,